A Highly Efficient Human Cell-free Translation System

Overview

Journal bioRxiv

Date 2023 Feb 17

PMID 36798401

Authors

Nikolay A Aleksashin

Stacey Tsai-Lan Chang

Jamie H D Cate

Affiliations

Soon will be listed here.

Abstract

Cell-free protein synthesis (CFPS) systems enable easy expression of proteins with many scientific, industrial, and therapeutic applications. Here we present an optimized, highly efficient human cell-free translation system that bypasses many limitations of currently used systems. This CFPS system is based on extracts from human HEK293T cells engineered to endogenously express GADD34 and K3L proteins, which suppress phosphorylation of translation initiation factor eIF2α. Overexpression of GADD34 and K3L proteins in human cells significantly simplifies cell lysate preparation. The new CFPS system improves the translation of 5' cap-dependent mRNAs as well as those that use internal ribosome entry site (IRES) mediated translation initiation. We find that expression of the GADD34 and K3L accessory proteins before cell lysis maintains low levels of phosphorylation of eIF2α in the extracts. During translation reactions, eIF2α phosphorylation increases moderately in a GCN2-dependent fashion that can be inhibited by GCN2 kinase inhibitors. We also find evidence for activation of regulatory pathways related to eukaryotic elongation factor 2 (eEF2) phosphorylation and ribosome quality control in the extracts. This new CFPS system should be useful for exploring human translation mechanisms in more physiological conditions outside the cell.

References

Mills E, Green R . Ribosomopathies: There's strength in numbers. Science. 2017; 358(6363). DOI: 10.1126/science.aan2755. View

Liaud N, Horlbeck M, Gilbert L, Gjoni K, Weissman J, Cate J . Cellular response to small molecules that selectively stall protein synthesis by the ribosome. PLoS Genet. 2019; 15(3):e1008057. PMC: 6436758. DOI: 10.1371/journal.pgen.1008057. View

Ovchinnikov L, Motuz L, Natapov P, Averbuch L, Wettenhall R, Szyszka R . Three phosphorylation sites in elongation factor 2. FEBS Lett. 1990; 275(1-2):209-12. DOI: 10.1016/0014-5793(90)81473-2. View

Goto Y, Suga H . The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides. Acc Chem Res. 2021; 54(18):3604-3617. DOI: 10.1021/acs.accounts.1c00391. View

Heide C, Buldum G, Moya-Ramirez I, Ces O, Kontoravdi C, Polizzi K . Design, Development and Optimization of a Functional Mammalian Cell-Free Protein Synthesis Platform. Front Bioeng Biotechnol. 2021; 8:604091. PMC: 7884609. DOI: 10.3389/fbioe.2020.604091. View

Rakotondrafara A, Hentze M . An efficient factor-depleted mammalian in vitro translation system. Nat Protoc. 2011; 6(5):563-71. DOI: 10.1038/nprot.2011.314. View

Asano K, Clayton J, Shalev A, Hinnebusch A . A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo. Genes Dev. 2000; 14(19):2534-46. PMC: 316978. DOI: 10.1101/gad.831800. View

Ramelot T, Cort J, Yee A, Liu F, Goshe M, Edwards A . Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2alpha. J Mol Biol. 2002; 322(5):943-54. DOI: 10.1016/s0022-2836(02)00858-6. View

Brazeau J, Rosse G . Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2. ACS Med Chem Lett. 2014; 5(4):282-3. PMC: 4027772. DOI: 10.1021/ml500052f. View

10.

Jammi N, Whitby L, Beal P . Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun. 2003; 308(1):50-7. DOI: 10.1016/s0006-291x(03)01318-4. View

11.

Jaafar Z, Oguro A, Nakamura Y, Kieft J . Translation initiation by the hepatitis C virus IRES requires eIF1A and ribosomal complex remodeling. Elife. 2016; 5. PMC: 5238962. DOI: 10.7554/eLife.21198. View

12.

Pelletier J, Sonenberg N . The Organizing Principles of Eukaryotic Ribosome Recruitment. Annu Rev Biochem. 2019; 88:307-335. DOI: 10.1146/annurev-biochem-013118-111042. View

13.

Pestova T, Lomakin I, Hellen C . Position of the CrPV IRES on the 40S subunit and factor dependence of IRES/80S ribosome assembly. EMBO Rep. 2004; 5(9):906-13. PMC: 1299141. DOI: 10.1038/sj.embor.7400240. View

14.

Mureev S, Kovtun O, Nguyen U, Alexandrov K . Species-independent translational leaders facilitate cell-free expression. Nat Biotechnol. 2009; 27(8):747-52. DOI: 10.1038/nbt.1556. View

15.

Penzo M, Carnicelli D, Montanaro L, Brigotti M . A reconstituted cell-free assay for the evaluation of the intrinsic activity of purified human ribosomes. Nat Protoc. 2016; 11(7):1309-25. DOI: 10.1038/nprot.2016.072. View

16.

Panthu B, Ohlmann T, Perrier J, Schlattner U, Jalinot P, Elena-Herrmann B . Cell-Free Protein Synthesis Enhancement from Real-Time NMR Metabolite Kinetics: Redirecting Energy Fluxes in Hybrid RRL Systems. ACS Synth Biol. 2017; 7(1):218-226. DOI: 10.1021/acssynbio.7b00280. View

17.

Lee A, Kranzusch P, Cate J . eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015; 522(7554):111-4. PMC: 4603833. DOI: 10.1038/nature14267. View

18.

EHRENFELD E, Hunt T . Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A. 1971; 68(5):1075-8. PMC: 389116. DOI: 10.1073/pnas.68.5.1075. View

19.

Kampen K, Sulima S, Vereecke S, De Keersmaecker K . Hallmarks of ribosomopathies. Nucleic Acids Res. 2019; 48(3):1013-1028. PMC: 7026650. DOI: 10.1093/nar/gkz637. View

20.

Atkins J, Loughran G, Bhatt P, Firth A, Baranov P . Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use. Nucleic Acids Res. 2016; 44(15):7007-78. PMC: 5009743. DOI: 10.1093/nar/gkw530. View